EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

mRNA-based cancer vaccines: A new frontier in personalized immunotherapy

Pankaj Garg, Ravi Salgia, Sharad S Singhal

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189577 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Pankaj Garg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, GLA University, NH-19, Mathura-Delhi Road, Mathura, Uttar Pradesh 281406, India. Hauptthemen laut MEDLINE: Cancer Vaccines, Precision Medicine, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The advancement of mRNA technology has rejuvenated the cancer treatment immunotherapy field by providing a flexible and scalable platform to generate tumor-associated or patient-specific neoantigens, which induces strong cytotoxic and helper T-cell outcomes and also immunologically stimulates innate immunity in the body at the same time. In contrast to conventional vaccines, mRNA preparations are non-integrative, safe, and scalable, allowing personalization of mutational landscape-based vaccines much faster due to the unique mutations of tumors in individuals. Early clinical trials in melanoma, breast, glioblastoma, and pancreatic cancer have revealed encouraging immunogenicity results, especially when used along with checkpoint inhibitors or other complementary therapies. The recent news of discovering the mRNA cancer vaccine, Enteromix, in Russia, also points to the potential of the translation and the global trend of this technology, which is both effective in treatment and accessible in clinical practice. Although the issues such as heterogeneity of the tumors, antigen escape, delivery efficiency, and manufacturing logistics are present, the development of artificial intelligence, multi-omics integration, and next-generation delivery systems will address these challenges. This review gives an overview of the concepts and principles, types, delivery mechanisms, clinical applications, and future perspective of mRNA-based cancer vaccines with a focus to its revolutionary contribution to personalized oncology and the overall next-generation immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesPrecision MedicineImmunotherapyNeoplasmsRNA, MessengerHumansAntigens, NeoplasmAnimals

Stichwörter der Autor:innen

Cancer immunotherapyCombination therapyDelivery platformsNeoantigensmRNA vaccines

Substanzen

Cancer VaccinesAntigens, NeoplasmRNA, Messenger

Autor:innen und Institutionen

  • Department of Chemistry, GLA University, NH-19, Mathura-Delhi Road, Mathura, Uttar Pradesh 281406, India.
  • Department of Medical Oncology and Therapeutic Research, Beckman Research Institute of City of Hope, 1500 E Duarte Road, Duarte, CA 91010, USA.
  • Department of Medical Oncology and Therapeutic Research, Beckman Research Institute of City of Hope, 1500 E Duarte Road, Duarte, CA 91010, USA. Electronic address: ssinghal@coh.org.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute
  • Beckman Research Institute, City of Hope
  • U.S. Department of Defense

Zitieren

APA

Garg, P., Salgia, R., & Singhal, S. S. (2026). mRNA-based cancer vaccines: A new frontier in personalized immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189577

Vancouver

Garg P, Salgia R, Singhal SS. mRNA-based cancer vaccines: A new frontier in personalized immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189577

BibTeX
@article{Garg2026,
  author = {Garg, Pankaj and Salgia, Ravi and Singhal, Sharad S},
  title = {mRNA-based cancer vaccines: A new frontier in personalized immunotherapy},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189577}
}
Kostenlos starten →